Pure Global

"Serpso" red blood cell preservation dilution - Taiwan Registration 4b98bbeb1f9be1d1cc6eed9b13ad7999

Access comprehensive regulatory information for "Serpso" red blood cell preservation dilution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 4b98bbeb1f9be1d1cc6eed9b13ad7999 and manufactured by CSL LIMITED. The authorized representative in Taiwan is GIRAFFES PHARMACEUTICAL COMPANY LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
4b98bbeb1f9be1d1cc6eed9b13ad7999
Registration Details
Taiwan FDA Registration: 4b98bbeb1f9be1d1cc6eed9b13ad7999
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Serpso" red blood cell preservation dilution
TW: โ€œๅกž็ˆพๆ™ฎ็ดขโ€็ด…่ก€็ƒไฟๅญ˜็จ€้‡‹ๆถฒ
Risk Class 1
Cancelled

Registration Details

4b98bbeb1f9be1d1cc6eed9b13ad7999

DHA04400947303

Company Information

Australia

Product Details

Limited to the first level identification range of blood cell thinners (B.8200) of the management methods for medical devices.

B Hematology, pathology, and genetics

B.8200 Hemocytodilant

import

Dates and Status

Nov 05, 2010

Nov 05, 2015

Apr 25, 2018

Cancellation Information

Logged out

่‡ช่กŒ้ตๅ…ฅ